This inventor holds 1 USPTO granted patent. Top assignees: Katholieke Universiteit Leuven Ku Leuven Research & Development, Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 33 Years Active: 2026
Title: Sven Verdonck: Innovator in Pharmaceutical Research
Introduction
Sven Verdonck is a notable inventor based in Diest, Belgium. He has made significant contributions to the field of pharmaceutical research, particularly in the development of receptor antagonists. His work focuses on innovative methods for treating diseases associated with specific receptors.
Latest Patents
Sven Verdonck holds 1 patent related to MRGX receptor antagonists. This invention pertains to a method for preventing or treating diseases associated with the MrgX2 receptor. It also includes MrgX2 antagonists and their physiologically acceptable salts. Furthermore, the invention encompasses pharmaceutical compositions and dosage forms that incorporate an MrgX2 antagonist.
Career Highlights
Throughout his career, Sven has worked with esteemed institutions such as Rheinische Friedrich-Wilhelms-Universität Bonn and Katholieke Universiteit Leuven. His research has contributed to advancements in understanding and treating receptor-related disorders.
Collaborations
Sven has collaborated with notable professionals in his field, including Christa Müller and Mohamad Wessam Alnouri. These partnerships have enhanced the scope and impact of his research.
Conclusion
Sven Verdonck's innovative work in pharmaceutical research, particularly with MRGX receptor antagonists, showcases his commitment to advancing medical science. His contributions are vital for developing new treatment methods for receptor-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile